VNDA
Vanda Pharmaceuticals Inc
5.00$
-3.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +674.4% | -11.2% | +4.7% | +3.5% | +48.0% | +119.2% | +32.8% | +13.1% | +17.0% | +17.6% | +9.2% | +8.3% | -5.3% | -24.3% | +3.2% | +8.7% | |
| – | – | – | – | -34.2% | -94.5% | +51.4% | +812.3% | -99.7% | +40,482.9% | -97.0% | +1,382.1% | +5.3% | -27.8% | +14.9% | +19.4% | -4.6% | +9.7% | -5.3% | -27.6% | -35.6% | +15.3% | |
| – | – | – | – | – | – | +1,768.6% | +1.4% | +4.2% | +3.9% | +43.4% | +78.0% | +40.3% | +21.4% | +17.2% | +17.4% | +10.9% | +8.1% | -5.3% | -16.3% | -2.7% | +8.3% | |
| – | +126.9% | +208.3% | -9.3% | -49.3% | -42.0% | -11.1% | +135.0% | +56.7% | -38.0% | -31.8% | +51.6% | +0.0% | +32.2% | +13.1% | +11.6% | +14.2% | +35.6% | +13.8% | -10.4% | -3.1% | +46.8% | |
| – | – | -42.9% | +140.5% | -11.9% | -17.9% | -57.2% | +13.2% | +20.9% | +77.2% | +223.8% | +1.9% | +21.3% | +24.5% | -13.7% | +19.7% | +1.1% | -8.3% | +14.1% | -8.8% | +18.4% | +64.7% | |
| – | +154.0% | +170.6% | +21.8% | -34.0% | -28.9% | -40.2% | +86.7% | +44.9% | -10.8% | +95.5% | +19.3% | +10.4% | +17.3% | -8.1% | +19.2% | +9.8% | +1.7% | +11.4% | -7.7% | +10.4% | +55.3% | |
| – | – | – | – | – | – | – | -228.2% | – | – | – | -300.3% | – | – | – | +4.9% | +19.4% | +54.8% | -85.0% | -320.4% | – | – | |
| – | – | – | -100.0% | – | – | -100.0% | – | – | – | – | – | – | – | – | – | -29.0% | -95.5% | +2,398.0% | – | – | – | |
| – | – | – | – | – | – | – | -210.5% | – | – | – | -297.5% | – | – | – | +14.5% | +9.0% | +33.8% | -73.3% | -43.9% | -461.6% | – | |
| – | +54.6% | -92.8% | +1,699.5% | +17,926.9% | – | – | -121.4% | – | – | – | – | – | +30.8% | +1.5% | -62,799.3% | – | +10.7% | -45.5% | -23.8% | -205.0% | – | |
| – | – | – | – | – | – | – | -236.3% | – | – | – | -297.5% | – | – | – | +358.4% | -79.8% | +42.1% | -81.1% | -60.0% | -853.3% | – | |
| – | – | – | – | – | – | – | -190.7% | – | – | – | – | – | – | – | +4.1% | +34.3% | +31.0% | -69.0% | -199.4% | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.